PMID- 37605676 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230823 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 15 IP - 7 DP - 2023 Jul TI - Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and Neurodegeneration. PG - e42259 LID - 10.7759/cureus.42259 [doi] LID - e42259 AB - Cardiovascular diseases and osteoporosis, seemingly unrelated disorders that occur with advanced age, share major pathogenetic mechanisms contributing to accelerated atherosclerosis and bone loss. Hyperhomocysteinemia (hHcy) is among these mechanisms that can cause both vascular and bone disease. In its more severe form, hHcy can present early in life as homocystinuria, an inborn error of metabolic pathways of the sulfur-containing amino acid methionine. In its milder forms, hHcy may go undiagnosed and untreated into adulthood. As such, hHcy may serve as a potential therapeutic target for cardiovascular disease, osteoporosis, thrombophilia, and neurodegeneration, collectively representing accelerated aging. Multiple trials to lower cardiovascular risk and improve bone density with homocysteine-lowering agents, yet none has proven to be clinically meaningful. To understand this unmet clinical need, this review will provide mechanistic insight into the pathogenesis of vascular and bone disease in hHcy, using homocystinuria as a model for accelerated atherosclerosis and bone density loss, a model for accelerated aging. CI - Copyright (c) 2023, Alkaissi et al. FAU - Alkaissi, Hussam AU - Alkaissi H AD - Internal Medicine, Kings County Hospital Center, Brooklyn, USA. AD - Internal Medicine, Veterans Affairs Medical Center, Brooklyn, USA. AD - Internal Medicine, State University of New York Downstate Medical Center, Brooklyn, USA. FAU - McFarlane, Samy I AU - McFarlane SI AD - Endocrinology, State University of New York Downstate Medical Center, Brooklyn, USA. LA - eng PT - Journal Article PT - Review DEP - 20230721 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC10440097 OTO - NOTNLM OT - accelerated aging OT - atherosclerosis OT - cardiovascular disease OT - classical homocystinuria OT - homocysteine metabolism OT - homocystinuria OT - hyperhomocysteinemia OT - osteoporosis OT - pathogenesis OT - thrombophilia COIS- The authors have declared that no competing interests exist. EDAT- 2023/08/22 06:42 MHDA- 2023/08/22 06:43 PMCR- 2023/07/21 CRDT- 2023/08/22 03:38 PHST- 2023/07/21 00:00 [accepted] PHST- 2023/08/22 06:43 [medline] PHST- 2023/08/22 06:42 [pubmed] PHST- 2023/08/22 03:38 [entrez] PHST- 2023/07/21 00:00 [pmc-release] AID - 10.7759/cureus.42259 [doi] PST - epublish SO - Cureus. 2023 Jul 21;15(7):e42259. doi: 10.7759/cureus.42259. eCollection 2023 Jul.